Alzheimer's disease and Abeta toxicity: from top to bottom. - Wikidata - awgldk - TriplyDB

Alzheimer's disease and Abeta toxicity: from top to bottom.

Alzheimer's disease and Abeta toxicity: from top to bottom.

http://www.wikidata.org/entity/Q34325378

about

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo.β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease Alzheimer's disease, amyloid peptide and synaptic dysfunction Behavioral stress fails to accelerate the onset and progression of plaque pathology in the brain of a mouse model of Alzheimer's disease Spreading of pathology in neurodegenerative diseases: a focus on human studies Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss Alzheimers Disease Synaptic abnormalities in a Drosophila model of Alzheimer's disease The concentration of soluble extracellular amyloid-β protein in acute brain slices from CRND8 mice.Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila.Chronic pre-treatment with memantine prevents amyloid-beta protein-mediated long-term potentiation disruption.Age-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice.Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons Amyloid-β peptide structure in aqueous solution varies with fragment size.Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.Epitope structure and binding affinity of single chain llama anti-β-amyloid antibodies revealed by proteolytic excision affinity-mass spectrometry.Alois Alzheimer and Alzheimer's disease: a centennial perspective.Incoordination between spikes and LFPs in Aβ1-42-mediated memory deficits in rats.Ion channel formation and membrane-linked pathologies of misfolded hydrophobic proteins: the role of dangerous unchaperoned molecules.Amyloid-β as a modulator of synaptic plasticity Alzheimer disease therapy: can the amyloid cascade be halted?Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein.Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways.Connecting the dots: trafficking of neurotrophins, lectins and diverse pathogens by binding to the neurotrophin receptor p75NTR.Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice.Single-channel quantitative multiplex reverse transcriptase-polymerase chain reaction for large numbers of gene products differentiates nondemented from neuropathological Alzheimer's disease.Amyloid, presenilins, and Alzheimer's disease.Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice.Modes of Aβ toxicity in Alzheimer's disease.Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms.

P2860

Q22252705-695C617D-1B35-48C8-A9A3-5932E976DFD0 Q24300901-2CD24819-C427-4FDA-9D5B-75F8E86458A1 Q26781608-FEF0EA39-6C2C-4F56-B2D2-43DD840E8E1D Q27005935-DD3F9D62-25F2-41FF-8662-03C13C9B2595 Q27321391-C4015B2E-7AD1-41E2-83BB-2A8F3836772A Q28082279-47C9B347-C8F1-4DA1-88B8-85FDC4C99EC9 Q28478362-8F17EC55-4CB3-48D7-A2D4-D69618BF6798 Q28592777-06A3F235-40D2-4CE6-AB87-1FF09EBE23E8 Q28820783-5C9C9ACC-DBDE-45C5-859B-1BB5729D5429 Q29614850-CDA56677-2846-4642-84F3-B4FE0BCB1A7D Q29892262-8B22ABCB-6CFA-4CE6-957F-A0B1EEBEE488 Q30573528-AD786E80-534B-46C8-9526-96CD70DD193E Q30994762-9215B025-1FDB-4024-B0FC-4A5DAF6DDD8C Q33283469-EFC3948C-6065-49C5-B33E-CCAE7C8BC17B Q33859443-CA710B5A-7B89-4ADA-8A62-6431641CAC3C Q33936347-1A4E6DBA-B671-47A6-BD40-CD7FF3EEB7BE Q34003920-D750C74D-A660-4A6E-B5EA-6ED8C3C603A2 Q34074414-B201F57B-E4E1-4BDB-B0EB-420C4B414711 Q34168300-4F6DA2C0-924E-4CF2-A138-9BC81DFD330A Q34236938-1D60681C-E5E9-4CCF-ABEE-7866A829DF40 Q34450675-B840881A-7291-4502-955A-A2D76DD98892 Q34480004-F4D7BB23-7F5A-43F8-8B8E-280E6DD7C6B7 Q34529106-A210B627-5B75-4181-9FEE-5712DC9C5DF9 Q34572251-2DD82418-2EEB-4A39-8C01-4F794AB01725 Q34579609-C6486FD3-3533-4F2E-A9C5-91FEE803E413 Q34775436-0DC86CD7-8346-4B24-BBE6-FC0122053F12 Q34814145-AAC050B0-E445-4E9D-A9B3-A508BD81ACDF Q34828328-FAC773EF-04AB-4273-AE31-C5A985E3E6E5 Q34881830-0C34914F-5371-4E6F-99E9-961BD11035B2 Q34923956-B8D5665E-A3F4-46FC-A7D0-A5D8FD6B5AB5 Q34961009-47D85803-8F78-4BCD-9912-3C18AB963502 Q34979557-D023F648-60BB-433C-B967-B4B7CCA31D79 Q35072126-7698DCE6-3EF2-42F9-B179-C187D338F7B9 Q35084882-426D7DC0-E33B-4795-B1B3-08DEEC4BC4F8 Q35094655-C6C846AE-D2DF-4D8F-A970-67924506ACDD Q35112198-E83527FA-CFF8-486D-9A61-6DA96BB7EC63 Q35213182-3C62FE95-A134-40A2-B44B-6FAB278F52B2 Q35218837-26BD93C2-553D-47AB-B7EE-7F3EF398A254 Q35235869-B756F69A-C55B-432D-A59E-957C1798C919 Q35576030-0EAF60B3-B60D-456C-B948-FB1C2CA912A7

P2860

Alzheimer's disease and Abeta toxicity: from top to bottom.

http://www.wikidata.org/entity/Q34325378

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Alzheimer's disease and Abeta toxicity: from top to bottom.

@ast

Alzheimer's disease and Abeta toxicity: from top to bottom.

@en

Alzheimer's disease and Abeta toxicity: from top to bottom.

@nl

type

label

Alzheimer's disease and Abeta toxicity: from top to bottom.

@ast

Alzheimer's disease and Abeta toxicity: from top to bottom.

@en

Alzheimer's disease and Abeta toxicity: from top to bottom.

@nl

prefLabel

Alzheimer's disease and Abeta toxicity: from top to bottom.

@ast

Alzheimer's disease and Abeta toxicity: from top to bottom.

@en

Alzheimer's disease and Abeta toxicity: from top to bottom.

@nl

P1433

Q34325378-5F208F66-2F58-45FE-B801-BD0810AD061B

P1476

Q34325378-1BF0ED76-B7C3-4E9A-8CDA-50F9BA1FBEEF

P2093

Q34325378-1DD759F6-AB3C-40CB-AAB6-6EF3608FABB5

Q34325378-9A9493D3-85F5-44ED-B509-D854964DF5FA

Q34325378-9C42DF38-ECB4-4600-A09A-D64AF2158F78

P2860

Q34325378-021C951B-6793-49B4-A660-CD8161882ED5

Q34325378-16186879-5C28-4139-9EE6-35C8613ED3E4

Q34325378-1A54F7D1-6FFC-4CE7-9DA3-0B83A56AA1A2

Q34325378-1F76FAFF-B876-4AA4-A246-11FEB062EA21

Q34325378-2D786C95-2E84-4195-AD33-84175B1572CD

Q34325378-2D924EA6-D0FA-43ED-A44D-137AF69CA77F

Q34325378-303A32FB-43A3-46C0-A0E6-9A3D4CA59B20

Q34325378-374D2835-AB8B-43C8-9C23-776E80BCF219

Q34325378-388AA909-B5E4-431B-9EEF-D2E8C8F2B1F9

Q34325378-39476FFE-B4D3-4DDD-B0FB-8838E284ACD1

P2888

Q34325378-1B0850A5-F95D-4B0A-A249-9A9E7316EC1E

P304

Q34325378-0CF0F59E-B7DA-46A5-AA77-E58149C5FACB

P31

Q34325378-BCE530EE-D91A-4375-814E-76ED8F7E2711

P356

Q34325378-2A3DF69B-46C0-4919-B4B6-54A43457428F

P407

Q34325378-1FC573FE-EA6C-46C0-ACC1-CF00E533DD94

P433

Q34325378-78BCE2EF-02BB-4AD8-950C-99DD1480F460

P478

Q34325378-3A83A503-B481-46D3-BFFF-01E69818C875

P577

Q34325378-EB9F3AAB-8E3D-4C22-8EAE-58D70FA56AA9

P5875

Q34325378-07C4A979-96CC-44B9-9F33-A1CBA89BB5E1

P6179

Q34325378-1905FE5C-B52D-4393-A2AA-BBB6E052C8CF

P698

Q34325378-81F08600-3883-436D-A5B4-C9768A2962DC

P921

Q34325378-184E8B29-828E-4EAE-B9CE-0D90759DE791

P356

P1433

Nature Reviews Neuroscience

P1476

Alzheimer's disease and Abeta toxicity: from top to bottom.

@en

P2093

Bornstein JC

http://www.w3.org/2001/XMLSchema#string

Mok SS

http://www.w3.org/2001/XMLSchema#string

Small DH

http://www.w3.org/2001/XMLSchema#string

P2860

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

Neural networks and physical systems with emergent collective computational abilities

Neurotoxicity induces cleavage of p35 to p25 by calpain

alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity

Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalin

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs

P2888

P304

595-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/35086072

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232781825

http://www.w3.org/2001/XMLSchema#string

P6179

1000563080

http://www.w3.org/2001/XMLSchema#string

P698

11484003

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease